Enhancement drugs: are there limits to what we should enhance and why?
Abstract Substances, such as alcohol, opiates and cannabis, have been used by humans for millennia. Today, a much wider range…
Abstract Substances, such as alcohol, opiates and cannabis, have been used by humans for millennia. Today, a much wider range…
Abstract Recent studies have found that cannabinoids may improve neuropsychological performance, ameliorate negative symptoms, and have antipsychotic properties for a…
Abstract Background: ErbB2-positive breast cancer is characterized by highly aggressive phenotypes and reduced responsiveness to standard therapies. Although specific ErbB2-targeted…
Abstract Irritability is a common neuropsychiatric feature of Huntington’s disease (HD), with prevalences varying from 38% to 73%. Similar prevalences…
Abstract Cannabis contains the psychoactive component delta9-tetrahydrocannabinol (delta9-THC), and the non-psychoactive components cannabidiol (CBD), cannabinol, and cannabigerol. It is well-known…
Abstract Background: Several epidemiological studies have shown that cannabis; the most widely used illegal drug in the world, is associated…
Abstract Cannabinoids are used clinically on a subacute basis as prophylactic agonist antiemetics for the prevention of nausea and vomiting…
Abstract Background: Methamphetamine (MA) is a new arrival to the Southeastern United States (US). Incidence of HIV is also increasing…
Abstract Background: Adult neurogenesis is a particular example of brain plasticity that is partially modulated by the endocannabinoid system. Whereas…
Abstract Rationale: Cannabis is the most commonly used illicit drug among pregnant women. Since the endocannabinoid system plays a crucial…